Market Place
Sourcing Support
All News #Library
Biotech
Immunovant Updates Corporate Progress And Q2 Financials Update
10 Nov 2025 //
GLOBENEWSWIRE
Immunovant Announces Positive Results for MG and CIDP Studies
20 Mar 2025 //
PRESS RELEASE
Immunovant: Positive Batoclimab Myasthenia Gravis & CIDP Results
19 Mar 2025 //
GLOBENEWSWIRE
Immunovant Investor Webcast on March 19 to Review Batoclimab Result
18 Mar 2025 //
GLOBENEWSWIRE
Immunovant Reports Financial Results for Quarter Ended Dec 31, 2024
06 Feb 2025 //
GLOBENEWSWIRE
Immunovant Announces $450 Million Private Placement
13 Jan 2025 //
GLOBENEWSWIRE
Immunovant to Present Phase 2 Graves’ Disease Data at ATA Meeting
29 Oct 2024 //
GLOBENEWSWIRE
Immunovant Provides Update on Graves’ Disease Development Program
09 Sep 2024 //
GLOBENEWSWIRE
Immunovant Awarded U.S. Patent for IMVT-1402
12 Mar 2024 //
GLOBENEWSWIRE
Immunovant Reports Positive Phase 2 Results for Batoclimab in Graves™ Disease
20 Dec 2023 //
GLOBENEWSWIRE
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results
28 Nov 2023 //
GLOBENEWSWIRE
Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD
26 Sep 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.